Peter Hollander

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Hodgkin Lymphoma

Disease Activity

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression. Blood advances 8 (16) (2024)
Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Mostafa Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
CD163+ macrophages in mantle cell lymphoma induce activation of pro-survival pathways and immune suppression. Blood advances (2024)
Joana Matos Rodrigues, Lavanya Lokhande, Lina Maj Olsson, May Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandström Gerdtsson, Mats Jerkeman, Sara Ek
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression. Blood advances 8 (16) (2024)
Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander
Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases. Biomolecules 13 (2) (2023)
Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander
Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases. Biomolecules 13 (2) (2023)
Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander
Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases. Biomolecules 13 (2) (2023)
Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Katariina Räty, Martin Hutchings, Caroline E Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy-treated mantle cell lymphoma. Blood advances (2023)
Maysaa Abdulla, Christer Sundström, Cecilia Lindskog, Peter Hollander
Expression of IDO1 and PD-L2 in Patients with Benign Lymphadenopathies and Association with Autoimmune Diseases. Biomolecules 13 (2) (2023)
Erik Hellbacher, Christian Hartmann Geisler, Daniel Molin, Eva Baecklund, Peter Hollander
Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases-A Possible Association with High Rheumatoid Arthritis Disease Activity. Cancers 14 (6) (2022)
Karin Paulsen, Millaray Marincevic, Lucia Cavelier, Peter Hollander, Rose-Marie Amini
LymphoTrack Is Equally Sensitive as PCR GeneScan and Sanger Sequencing for Detection of Clonal Rearrangements in ALL Patients. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Alex Reza Gholiha, Peter Hollander, Liza Löf, Ingrid Glimelius, Gustaf Hedstrom, Daniel Molin, Henrik Hjalgrim, Karin E Smedby, Jamileh Hashemi, Rose-Marie Amini, Gunilla Enblad
Checkpoint CD47 expression in classical Hodgkin lymphoma. British journal of haematology 197 (5) (2022)
Alex Reza Gholiha, Peter Hollander, Liza Löf, Anders O Larsson, Jamileh Hashemi, Johan Mattsson Ulfstedt, Daniel Molin, Rose-Marie Amini, Eva Freyhult, Masood Kamali-Moghaddam, Gunilla Enblad
Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue. Cancers 14 (1) (2021)
Andreea Sima, Peter Hollander, Eva Baecklund, Karin E Smedby, Gunilla Enblad, Rose-Marie Amini
Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden. British journal of haematology 194 (3) (2021)
Joana Matos Rodrigues, Anna Nikkarinen, Peter Hollander, Caroline E Weibull, Riikka Räty, Arne Kolstad, Rose-Marie Amini, Anna Porwit, Mats Jerkeman, Sara Ek, Ingrid Glimelius
Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. British journal of haematology 193 (3) (2021)
Rose-Marie Amini, Viktor Ljungström, Maysaa Abdulla, Lucia Cavelier, Tatjana Pandzic, Peter Hollander, Gunilla Enblad, Panagiotis Baliakas
Clonal hematopoiesis in patients with high-grade B-cell lymphoma is associated with inferior outcome. American journal of hematology (2020)
Maysaa Abdulla, Priscilla Guglielmo, Peter Hollander, Gunnar Åström, Håkan Ahlström, Gunilla Enblad, Rose-Marie Amini
Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma. European journal of haematology 104 (3) (2019)
Maysaa Abdulla, Peter Hollander, Tatjana Pandzic, Larry Mansouri, Susanne Bram Ednersson, Per-Ola Andersson, Magnus Hultdin, Maja Fors, Martin Erlanson, Sofie Degerman, Helga Munch Petersen, Fazila Asmar, Kirsten Grønbaek, Gunilla Enblad, Lucia Cavelier, Richard Rosenquist, Rose-Marie Amini
Cell-of-origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B-cell lymphoma. American journal of hematology 95 (1) (2019)
Alex Reza Gholiha, Peter Hollander, Gustaf Hedstrom, Christer Sundstrom, Daniel Molin, Karin E Smedby, Henrik Hjalgrim, Ingrid Glimelius, Rose-Marie Amini, Gunilla Enblad
High tumour plasma cell infiltration reflects an important microenvironmental component in classic Hodgkin lymphoma linked to presence of B-symptoms. British journal of haematology 184 (2) (2018)
Peter Hollander, Rose-Marie Amini, Beatrice Ginman, Daniel Molin, Gunilla Enblad, Ingrid Glimelius
Expression of PD-1 and PD-L1 increase in consecutive biopsies in patients with classical Hodgkin lymphoma. PloS one 13 (9) (2018)
Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, Gunilla Enblad, Maja Ludvigsen, Julie Mortensen, Rose-Marie Amini, Stephen Hamilton-Dutoit, Francesco d'Amore, Daniël G M Molin, Ingrid Glimelius
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome. Blood advances 1 (18) (2017)
Peter Hollander, Klaus Rostgaard, Karin E Smedby, Daniel Molin, Angelica Loskog, Peter de Nully Brown, Gunilla Enblad, Rose-Marie Amini, Henrik Hjalgrim, Ingrid Glimelius
An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome. European journal of haematology 100 (1) (2017)